A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients

Journal of Clinical Psychiatry

Volumn 63, Issue 7, 2002, Pages 585-590

  Javitt, Daniel C ^a   Cienfuegos, Angel ^a   Miniati, Mario ^a   Silipo, Gail ^a   Levine, Jerome ^a   Allingham, Baerbel H ^a   Robinson, James ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; DATA BASE; DRUG EFFICACY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036076837     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0708     Document Type: Article

References (11)

1. Treatment of negative and cognitive symptoms
2. Effectiveness of secondgeneration antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
3. A naturalistic outcome study of risperidone treatment among hospital patients
4. Risperidone use at a state hospital: A clinical audit 2 years after the first wave of risperidone prescriptions
5. Effectiveness of antipsychotic therapy in a naturalistic setting: A comparison between risperidone, perphenazine, and haloperidol
6. A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness
7. A dose-outcome analysis of risperidone
8. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine
9. Economic outcomes of antipsychotic agents in a Medicaid population: Traditional agents vs risperidone
10. Utilization of depot neuroleptic medication in psychiatric inpatients